Phenomenex to present two workshops at Pittcon 2012
Phenomenex has announced that it will present two workshops at Pittcon 2012.
Phenomenex has announced that it will present two workshops at Pittcon 2012.
The first is entitled “UHPLC Beyond Reversed Phase: Expanding Application Areas Beyond Small Molecules” and will be presented on Wednesday 14 March at 8:00 a.m. in Room 308C. Speakers will include industry experts from Genentech, Integrated DNA Technologies, Mannkind, Waters and Phenomenex. There will be discussions on the impacts of recent advances in UHPLC instrument and column technology on characterization of proteins, oligonucleotides and other biologically relevant analytes.
The second presentation is “Analytical and Spectroscopic Advances and Their Impact on Biofuel Analysis” and will be presented on Thursday 15 March at 8:00 a.m. in Room 313. Speakers from Phenomenex and Shimadzu will discuss the current state of analytical techniques for biofuels research and production, as well as new advances.
For more information please visit ref="http://www.phenomenex.com">www.phenomenex.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
